fda cder regulatory science: patient-focused drug development
Published 6 years ago • 4.6K plays • Length 3:41Download video MP4
Download video MP3
Similar videos
-
1:11
about fda’s regulatory science program
-
2:30
how regulatory science benefits patients
-
3:01
fda cder regulatory science: improving drug review with data standards
-
1:59:38
public webinar: patient-focused drug development draft guidance 4
-
3:56
fda cder regulatory science: real world evidence
-
7:34:28
fda's rare disease day 2024—dedicated to patients and providers
-
54:28
overview of non-clinical assessment in drug development (8/14) redi 2017
-
5:47
how biomarkers can improve the drug development process
-
3:44
fda cder regulatory science: the importance of partnership and consortia
-
0:59
patient focused drug development and the fda
-
0:15
what is fda’s role in regulating drugs? (15 seconds)
-
2:34:13
public webinar: patient-focused drug development draft guidance 3
-
5:06
what is regulatory science? (video-full version)
-
11:49
janet woodcock, fda, on future innovation in drug development
-
35:58
uncovering the fda: drug development
-
36:06
what can cder do for you? (3of15) redi annual conference – may 29-30, 2019
-
37:46
clinical pharmacology regulatory sciences in drug development and precision medicine
-
7:02
keynote - bioanalysis 2020
-
43:14
introduction to regulatory science at the fda
-
35:51
orange book exclusivity: part ii - pediatric, orphan, and gain
-
17:17
fda meetings drug development process | regulatory affairs |
-
1:57:53
public meeting: using methods from pfdd guidance 1 and guidance 2 meeting #2